{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:36:05Z","timestamp":1778056565016,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10620-021-06868-9","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T03:02:50Z","timestamp":1614308570000},"page":"4568-4569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-9467","authenticated-orcid":false,"given":"Xiaoze","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"6868_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06716-2","author":"ML Kloster","year":"2020","unstructured":"Kloster ML, Ren A, Shah KY et al. High incidence of hepatic encephalopathy after viatorr controlled expansion transjugular intrahepatic portosystemic shunt creation. Dig Dis Sci. (Epub ahead of print). https:\/\/doi.org\/10.1007\/s10620-020-06716-2.","journal-title":"Dig Dis Sci."},{"key":"6868_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","volume":"42","author":"R Miraglia","year":"2019","unstructured":"Miraglia R, Maruzzelli L, Di Piazza A et al. Transjugular intrahepatic portosystemic shunt using the new gore viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience . Cardiovasc Intervent Radiol. 2019;42:78\u201386","journal-title":"Cardiovasc Intervent Radiol."},{"key":"6868_CR3","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00270-020-02512-7","volume":"43","author":"WM Coronado","year":"2020","unstructured":"Coronado WM, Ju C, Bullen J et al. Predictors of occurrence and risk of hepatic encephalopathy after tips creation: a 15-year experience. Cardiovasc Intervent Radiol. 2020;43:1156\u20131164","journal-title":"Cardiovasc Intervent Radiol."},{"key":"6868_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","volume":"114","author":"M Casado","year":"1998","unstructured":"Casado M, Bosch J, Garc\u00eda-Pag\u00e1n JC et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.  Gastroenterology. 1998;114:1296\u20131303","journal-title":"Gastroenterology."},{"key":"6868_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.15403\/jgld.2014.1121.243.yao","volume":"24","author":"J Yao","year":"2015","unstructured":"Yao J, Zuo L, An G et al. Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension.  J Gastrointest Liver Dis JGLD. 2015;24:301\u2013307","journal-title":"J Gastrointest Liver Dis JGLD."},{"key":"6868_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.018","author":"J Bosch","year":"2020","unstructured":"Bosch J. Small diameter shunts should lead to safe expansion of the use of TIPS. J Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.jhep.2020.09.018.","journal-title":"J Hepatol."},{"key":"6868_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ajg.2016.29","volume":"111","author":"S Nardelli","year":"2016","unstructured":"Nardelli S, Gioia S, Pasquale C et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.  Am J Gastroenterol 2016;111:523\u2013528","journal-title":"Am J Gastroenterol"},{"key":"6868_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","volume":"69","author":"D Tripathi","year":"2020","unstructured":"Tripathi D, Stanley AJ, Hayes PC et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.  Gut 2020;69:1173\u20131192","journal-title":"Gut"},{"issue":"1","key":"6868_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1440-1746.2006.04697.x","volume":"23","author":"HH Chung","year":"2008","unstructured":"Chung HH, Razavi MK, Sze DY, Frisoli JK, Kee ST, Dake MD et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol. 2008;23:95\u2013101","journal-title":"J Gastroenterol Hepatol."},{"issue":"5","key":"6868_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/BF01320309","volume":"31","author":"G D'Amico","year":"1986","unstructured":"D\u2019Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986;31:468\u2013475","journal-title":"Dig Dis Sci."},{"issue":"1","key":"6868_CR11","first-page":"42","volume":"23","author":"M Coltorti","year":"1991","unstructured":"Coltorti M, Del Vecchio-Blanco C, Caporaso N, Gallo C, Castellano L. Liver cirrhosis in Italy. A multicentre study on presenting modalities and the impact on health care resources. National Project on Liver Cirrhosis Group. Ital J Gastroenterol. 1991;23:42\u201348","journal-title":"Ital J Gastroenterol."},{"issue":"1","key":"6868_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0168-8278(01)00129-5","volume":"35","author":"P Amodio","year":"2001","unstructured":"Amodio P, Del Piccolo F, Petteno E et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol. 2001;35:37\u201345","journal-title":"J Hepatol."},{"issue":"4","key":"6868_CR13","doi-asserted-by":"publisher","first-page":"100122","DOI":"10.1016\/j.jhepr.2020.100122","volume":"2","author":"JC Garcia-Pagan","year":"2020","unstructured":"Garcia-Pagan JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep. 2020;2:100122","journal-title":"JHEP Rep."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06868-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06868-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06868-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:23:13Z","timestamp":1636741393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06868-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6868"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06868-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest. Disclosures not related to this work: Ron C. Gaba receives research support from Guerbet USA LLC, Janssen Research & Development LLC, and the United States National Institutes of Health. He serves as a consultant for Sus Clinicals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, ethical approval is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, consent for publication is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}